Previous Record Next Record

Psychedelic Medicine: New Frontiers in Palliative Care
Oct 27, 2017
Seattle, WA

Sponsored by the UW Center for Law, Science and Global Health, the End of Life Liberty Project, and the Drug Policy Alliance. Research has shown that psychedelic drugs such as psilocybin and MDMA may offer significant benefit for patients struggling at the end of life and those with major depressions and treatment-resistant PTSD. This 1-day conference will bring together doctors, scientific researchers, attorneys and ethicists to consider the medical, legal and ethical implications of this evolving research.

Featured speakers include MAPS Executive Director Rick Doblin, Washington State Representative Roger Goodman, End of Life Liberty Project Executive Director Kathryn Tucker, and Ethan Nadelmann, founder of the Drug Policy Alliance.

Contact: Email:

Submission Deadline: n/a